We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWO icon
76
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.52M 0.31%
37,907
-200
-0.5% -$7.91K
KMB icon
77
Kimberly-Clark
KMB
$36.6B
$1.52M 0.31%
16,809
– –
HPQ icon
78
HP
HPQ
$24.6B
$1.46M 0.3%
152,618
-13,851
-8% -$153K
LOW icon
79
Lowe's Companies
LOW
$118B
$1.45M 0.3%
30,393
– –
ABBV icon
80
AbbVie
ABBV
$455B
$1.44M 0.3%
32,268
-497
-2% -$22K
MAN icon
81
ManpowerGroup
MAN
$2.41B
$1.4M 0.29%
19,300
– –
EEM icon
82
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$1.37M 0.28%
33,640
+400
+1% +$15.8K
VOD icon
83
Vodafone
VOD
$37.2B
$1.37M 0.28%
38,110
-490
-1% -$15.5K
YUM icon
84
Yum! Brands
YUM
$43.3B
$1.35M 0.28%
26,322
-67
-0.3% -$3.48K
EEP
85
DELISTED
Enbridge Energy Partners
EEP
$1.33M 0.27%
43,640
-700
-2% -$21.5K
AMT icon
86
American Tower
AMT
$81.3B
$1.33M 0.27%
17,900
+200
+1% +$14.4K
F icon
87
Ford
F
$59.3B
$1.31M 0.27%
77,641
+1,014
+1% +$17.1K
MAC icon
88
Macerich
MAC
$7.22B
$1.29M 0.27%
22,795
– –
ACAD icon
89
Acadia Pharmaceuticals
ACAD
$4.55B
$1.28M 0.26%
+46,550
New +$973K
IBB icon
90
iShares Biotechnology ETF
IBB
$9.52B
$1.27M 0.26%
18,135
-150
-0.8% -$9.83K
SBUX icon
91
Starbucks
SBUX
$121B
$1.27M 0.26%
32,920
+202
+0.6% +$7.26K
IEO icon
92
iShares US Oil & Gas Exploration & Production ETF
IEO
$572M
$1.26M 0.26%
16,245
+1,255
+8% +$95.1K
CI icon
93
Cigna
CI
$76.1B
$1.26M 0.26%
16,425
– –
COP icon
94
ConocoPhillips
COP
$145B
$1.24M 0.26%
17,867
+2
+0% +$133
DUK icon
95
Duke Energy
DUK
$98.4B
$1.24M 0.26%
18,510
-783
-4% -$53.4K
EMC
96
DELISTED
EMC CORPORATION
EMC
$1.19M 0.25%
46,600
– –
VEA icon
97
Vanguard FTSE Developed Markets ETF
VEA
$230B
$1.19M 0.25%
29,930
– –
XRX icon
98
Xerox
XRX
$456M
$1.15M 0.24%
42,402
-1,593
-4% -$41.8K
DWCH
99
DELISTED
Datawatch Corp
DWCH
$1.14M 0.23%
40,667
+4,166
+11% +$97.4K
HSY icon
100
Hershey
HSY
$35.9B
$1.08M 0.22%
11,694
– –
2 3
4
5 6

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.